• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ILA 0.00% 16.5¢

ISLAND PHARMACEUTICALS LIMITED - Discussion

Island Pharmaceuticals Limited is an Australia-based drug repurposing company, focused on... Island Pharmaceuticals Limited is an Australia-based drug repurposing company, focused on areas of need for antiviral therapeutics to address infectious diseases. The Company's lead asset is ISLA-101, a drug, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Island Pharmaceuticals Limited

Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX News
ASX News
ASX News
ASX News
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $9.897M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $27.55K 163.0K

Buyers (Bids)

No. Vol. Price($)
2 61166 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 961 1
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
Last
17.0¢
  Change
0.000 ( 3.03 %)
Open High Low Volume
17.0¢ 17.0¢ 17.0¢ 82468
Last updated 15.01pm 22/11/2024 ?
ILA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.